The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 21, 2020
Filed:
Nov. 02, 2018
Applicant:
Pearl Therapeutics, Inc., Redwood City, CA (US);
Inventors:
Reinhard Vehring, Edmonton, CA;
Michael Steven Hartman, Millbrae, CA (US);
Adrian Edward Smith, Emerald Hills, CA (US);
Vidya B. Joshi, Redwood City, CA (US);
Sarvajna Kumar Dwivedi, Redwood City, CA (US);
Assignee:
Pearl Therapeutics, Inc., Redwood City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/12 (2006.01); A61K 9/14 (2006.01); A61K 31/58 (2006.01); A61K 31/137 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/40 (2006.01); A61K 31/46 (2006.01); A61K 31/56 (2006.01); A61K 31/135 (2006.01); A61K 31/16 (2006.01); A61K 31/192 (2006.01); A61K 31/194 (2006.01); A61K 31/573 (2006.01); A61M 15/00 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 9/008 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/16 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/194 (2013.01); A61K 31/40 (2013.01); A61K 31/46 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61M 15/0065 (2013.01);
Abstract
Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting βadrenergic receptor agonists via a metered dose inhaler. In particular embodiments, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.